Cargando…

肿瘤靶向治疗和免疫治疗——眼科系统毒性反应的诊治

The increasing use of target therapy and immunocheckpoint inhibitors in cancers has brought new hope of survival to patients with advanced tumors. However, more and more adverse side-effects and toxicities of these medications had been reported, affect almost all human organs including the eye. Thes...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6817431/
https://www.ncbi.nlm.nih.gov/pubmed/31650949
http://dx.doi.org/10.3779/j.issn.1009-3419.2019.10.09
_version_ 1783463417706708992
collection PubMed
description The increasing use of target therapy and immunocheckpoint inhibitors in cancers has brought new hope of survival to patients with advanced tumors. However, more and more adverse side-effects and toxicities of these medications had been reported, affect almost all human organs including the eye. These adverse effects may affect the entire ocular tissues, like eyelid, eye lashes, conjunctiva, cornea, uvea, retina, optic nerve and so on, which are always been ignored by patients and doctors. In this paper we will summarize the characteristics of the related ocular diseases and give our advice on how to diagnose and manage these diseases.
format Online
Article
Text
id pubmed-6817431
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher 中国肺癌杂志编辑部
record_format MEDLINE/PubMed
spelling pubmed-68174312019-11-12 肿瘤靶向治疗和免疫治疗——眼科系统毒性反应的诊治 Zhongguo Fei Ai Za Zhi 免疫检查点抑制剂专题 The increasing use of target therapy and immunocheckpoint inhibitors in cancers has brought new hope of survival to patients with advanced tumors. However, more and more adverse side-effects and toxicities of these medications had been reported, affect almost all human organs including the eye. These adverse effects may affect the entire ocular tissues, like eyelid, eye lashes, conjunctiva, cornea, uvea, retina, optic nerve and so on, which are always been ignored by patients and doctors. In this paper we will summarize the characteristics of the related ocular diseases and give our advice on how to diagnose and manage these diseases. 中国肺癌杂志编辑部 2019-10-20 /pmc/articles/PMC6817431/ /pubmed/31650949 http://dx.doi.org/10.3779/j.issn.1009-3419.2019.10.09 Text en 版权所有©《中国肺癌杂志》编辑部2019 https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/
spellingShingle 免疫检查点抑制剂专题
肿瘤靶向治疗和免疫治疗——眼科系统毒性反应的诊治
title 肿瘤靶向治疗和免疫治疗——眼科系统毒性反应的诊治
title_full 肿瘤靶向治疗和免疫治疗——眼科系统毒性反应的诊治
title_fullStr 肿瘤靶向治疗和免疫治疗——眼科系统毒性反应的诊治
title_full_unstemmed 肿瘤靶向治疗和免疫治疗——眼科系统毒性反应的诊治
title_short 肿瘤靶向治疗和免疫治疗——眼科系统毒性反应的诊治
title_sort 肿瘤靶向治疗和免疫治疗——眼科系统毒性反应的诊治
topic 免疫检查点抑制剂专题
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6817431/
https://www.ncbi.nlm.nih.gov/pubmed/31650949
http://dx.doi.org/10.3779/j.issn.1009-3419.2019.10.09
work_keys_str_mv AT zhǒngliúbǎxiàngzhìliáohémiǎnyìzhìliáoyǎnkēxìtǒngdúxìngfǎnyīngdezhěnzhì
AT zhǒngliúbǎxiàngzhìliáohémiǎnyìzhìliáoyǎnkēxìtǒngdúxìngfǎnyīngdezhěnzhì
AT zhǒngliúbǎxiàngzhìliáohémiǎnyìzhìliáoyǎnkēxìtǒngdúxìngfǎnyīngdezhěnzhì
AT zhǒngliúbǎxiàngzhìliáohémiǎnyìzhìliáoyǎnkēxìtǒngdúxìngfǎnyīngdezhěnzhì
AT zhǒngliúbǎxiàngzhìliáohémiǎnyìzhìliáoyǎnkēxìtǒngdúxìngfǎnyīngdezhěnzhì
AT zhǒngliúbǎxiàngzhìliáohémiǎnyìzhìliáoyǎnkēxìtǒngdúxìngfǎnyīngdezhěnzhì
AT zhǒngliúbǎxiàngzhìliáohémiǎnyìzhìliáoyǎnkēxìtǒngdúxìngfǎnyīngdezhěnzhì
AT zhǒngliúbǎxiàngzhìliáohémiǎnyìzhìliáoyǎnkēxìtǒngdúxìngfǎnyīngdezhěnzhì
AT zhǒngliúbǎxiàngzhìliáohémiǎnyìzhìliáoyǎnkēxìtǒngdúxìngfǎnyīngdezhěnzhì
AT zhǒngliúbǎxiàngzhìliáohémiǎnyìzhìliáoyǎnkēxìtǒngdúxìngfǎnyīngdezhěnzhì
AT zhǒngliúbǎxiàngzhìliáohémiǎnyìzhìliáoyǎnkēxìtǒngdúxìngfǎnyīngdezhěnzhì
AT zhǒngliúbǎxiàngzhìliáohémiǎnyìzhìliáoyǎnkēxìtǒngdúxìngfǎnyīngdezhěnzhì
AT zhǒngliúbǎxiàngzhìliáohémiǎnyìzhìliáoyǎnkēxìtǒngdúxìngfǎnyīngdezhěnzhì
AT zhǒngliúbǎxiàngzhìliáohémiǎnyìzhìliáoyǎnkēxìtǒngdúxìngfǎnyīngdezhěnzhì